1203 ORAL Long-term Survival in a Phase II Study of Belagenpumatucel-L (TGF-β Antisense Modified Tumour Cell Vaccine) in Non-small Cell Lung Cancer (NSCLC)
E. Juhasz, E. Carrier, D.F. ShawlerVolume:
47
Year:
2011
Language:
english
DOI:
10.1016/s0959-8049(11)70815-2
File:
PDF, 46 KB
english, 2011